Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Schrödinger, Inc. (SDGR)
USD16.46
+0.33 (+2.02%)
US NASDAQ Technology Software - Application
Address
1540 Broadway 10036
New York, NY, US
New York, NY, US
CEO
Ramy Farid
Website
schrodinger.com
IPO
2020-02-05
CIK 1490978 ISIN US80810D1037
Description
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD16.46
+0.33 (+2.02%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.64
Float Shares
58.62M
Free Float %
78.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.24% | -3.13% | +10.83% | +11.32% | -26.22% | -29.03% | -46.59% | -54.15% | -78.50% | -55.69% | -55.69% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (12 ratings, all time)
Buy
Price Targets & DCF
Current price
16.46
Low
18.00
+9.4%
Consensus
18.00
+9.4%
Median
18.00
+9.4%
High
18.00
+9.4%
Ratings Trend (MoM)
75% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 6 | -1 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 2 |
18.50
+12.4%
|
| All Time | 7 |
24.86
+51.1%
|
Quality scores
Altman Z-Score
0.73
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Software - Application: +13.0%+23.3% ★ Q1'26: -1.6% (vs Q1'25)
-
EPS growth Software - Application: +28.6%+45.1% ★ Q1'26: +1.2% (vs Q1'25)
-
FCF margin FCF growth · Software - Application: +45.3%+7.6% Q1'26: -29.6% (vs Q1'25)
-
EBIT margin Software - Application: +9.4%-40.0% Q1'26: -83.3% (vs Q1'25)
-
ROIC Software - Application: +7.5%-131.5% Q1'26: -905.9% (vs Q1'25)
-
Share dilution Software - Application: +0.0%+1.1% Q1'26: +1.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×-1.13× Q1'26: -0.55× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 4 EPS Ana. |
Dec 2028 4 Rev. Ana. 3 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
108.10M
est: 112.44M (-3.9%)
|
137.93M
est: 128.74M (+7.1%)
|
180.96M
est: 172.13M (+5.1%)
|
216.67M
est: 188.48M (+15.0%)
|
207.54M
est: 202.24M (+2.6%)
|
255.87M
est: 252.21M (+1.4%)
|
248.40M
203.07M – 320.85M
-1.5% YoY
|
253.55M
236.73M – 266.06M
+2.1% YoY
|
325.97M
318.84M – 333.10M
+28.6% YoY
|
371.80M
336.95M – 419.77M
+14.1% YoY
|
406.50M
368.40M – 458.95M
+9.3% YoY
|
| EBITDA |
-57.26M
est: -87.17M (+34.3%)
|
-108.60M
est: -73.08M (-48.6%)
|
-142.47M
est: -128.22M (-11.1%)
|
-171.90M
est: -140.35M (-22.5%)
|
-203.14M
est: -150.59M (-34.9%)
|
-96.30M
est: -187.81M (+48.7%)
|
-184.97M
-238.92M – -151.22M
+1.5% YoY
|
-188.80M
-198.12M – -176.28M
-2.1% YoY
|
-242.73M
-248.04M – -237.42M
-28.6% YoY
|
-276.86M
-312.58M – -250.91M
-14.1% YoY
|
-302.70M
-341.75M – -274.32M
-9.3% YoY
|
| EBIT |
-60.92M
est: -89.99M (+32.3%)
|
-111.44M
est: -110.16M (-1.2%)
|
-146.82M
est: -112.48M (-30.5%)
|
-177.45M
est: -144.69M (-22.6%)
|
-209.30M
est: -155.25M (-34.8%)
|
-102.33M
est: -193.61M (+47.1%)
|
-190.68M
-246.30M – -155.89M
+1.5% YoY
|
-194.64M
-204.24M – -181.73M
-2.1% YoY
|
-250.23M
-255.70M – -244.75M
-28.6% YoY
|
-285.41M
-322.24M – -258.66M
-14.1% YoY
|
-312.05M
-352.31M – -282.80M
-9.3% YoY
|
| Net Income |
-24.46M
est: -28.10M (+12.9%)
|
-100.39M
est: -77.83M (-29.0%)
|
-149.19M
est: -130.93M (-13.9%)
|
40.72M
est: -143.14M (+128.4%)
|
-187.12M
est: -192.21M (+2.6%)
|
-103.27M
est: -142.52M (+27.5%)
|
-165.36M
-247.79M – 8.85M
-16.0% YoY
|
-99.36M
-141.49M – -57.41M
+39.9% YoY
|
-2.01M
-47.73M – 74.90M
+98.0% YoY
|
-734.4K
-857.6K – -644.9K
+63.4% YoY
|
29.38M
25.80M – 34.31M
+4,100.0% YoY
|
| SGA |
59.69M
est: 70.84M (-15.7%)
|
86.16M
est: 86.39M (-0.3%)
|
121.47M
est: 94.42M (+28.6%)
|
136.37M
est: 118.02M (+15.5%)
|
139.59M
est: 126.64M (+10.2%)
|
136.37M
est: 157.93M (-13.7%)
|
155.54M
127.16M – 200.91M
-1.5% YoY
|
158.77M
148.24M – 166.61M
+2.1% YoY
|
204.12M
199.65M – 208.58M
+28.6% YoY
|
232.82M
210.99M – 262.86M
+14.1% YoY
|
254.54M
230.69M – 287.39M
+9.3% YoY
|
| EPS |
-0.44
est: -0.39 (-13.8%)
|
-1.43
est: -1.32 (-8.7%)
|
-2.10
est: -2.08 (-1.1%)
|
0.57
est: -1.99 (+128.7%)
|
-2.57
est: -2.43 (-5.6%)
|
-1.41
est: -1.96 (+28.1%)
|
-2.17
-3.37 – 0.12
-10.6% YoY
|
-1.38
-1.93 – -0.78
+36.3% YoY
|
-0.02
-0.65 – 1.02
+98.3% YoY
|
-0.01
-0.01 – -0.01
+57.7% YoY
|
0.40
0.35 – 0.47
+4,100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-135.26M
OE per share TTM
-1.84
Owner's Yield
-14.41%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
53.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
52
Total invested
44.39M
Insider transactions (90d)
1
Beneficial owners (>5%)
17
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bill & Melinda Gates Foundation Trust | 16.15M | 23.20% | — | 16.15M | — | — | OO | — | 2021-02-12 | ↗ |
| 2 | Melinda French Gates | 16.15M | 23.20% | — | 16.15M | — | — | IN | — | 2021-02-12 | ↗ |
| 3 | William H. Gates III | 16.15M | 23.20% | — | 16.15M | — | — | IN | — | 2021-02-12 | ↗ |
| 4 | (1) BlackRock, Inc. | 3.96M | 6.40% | 3.88M | — | 3.96M | — | HC | Delaware | 2023-02-03 | ↗ |
| 5 | ARK Investment Management LLC | 3.85M | 6.21% | 3.85M | — | 3.85M | — | IA | — | 2023-02-10 | ↗ |
| 6 | The Vanguard Group - 23-1945930 | 3.81M | 6.76% | — | — | — | 101.3K | IA | Pennsylvania For | 2021-02-10 | ↗ |
| 7 | David Rosen | 3.69M | 5.79% | — | 3.69M | — | — | IN | State of Delaware | 2024-11-13 | ↗ |
| 8 | Rubric Capital Management LP | 3.69M | 5.79% | — | 3.69M | — | — | IA, PN | State of Delaware | 2024-11-13 | ↗ |
| 9 | David E. Shaw | 2.40M | 3.90% | 4.3K | — | 2.40M | — | IN | — | 2021-12-01 | ↗ |
| 10 | Charles Ardai | 2.40M | 3.90% | 2.40M | — | — | — | IN | — | 2021-12-01 | ↗ |
| 11 | Schrodinger Equity Holdings, LLC | 2.40M | 3.90% | 2.40M | — | 2.40M | — | OO | — | 2021-12-01 | ↗ |
| 12 | Company, L.P. | 1.60M | 3.31% | — | 1.60M | — | — | PN | Delaware | 2020-02-10 | ↗ |
| 13 | James E. Flynn | 1.60M | 3.31% | — | 1.60M | — | — | IN | Delaware | 2020-02-10 | ↗ |
| 14 | Deerfield Mgmt IV, L.P. | 1.35M | 2.79% | — | 1.35M | — | — | PN | Delaware | 2020-02-10 | ↗ |
| 15 | Deerfield Private Design Fund IV, L.P. | 1.35M | 2.79% | — | 1.35M | — | — | PN | Delaware | 2020-02-10 | ↗ |
| 16 | Deerfield Mgmt, L.P. | 250.0K | 0.52% | — | 250.0K | — | — | PN | Delaware | 2020-02-10 | ↗ |
| 17 | Deerfield Partners, L.P. | 250.0K | 0.52% | — | 250.0K | — | — | PN | Delaware | 2020-02-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
52
-182 vs prev Q
New positions
8
Closed positions
180
Increased
22
Reduced
14
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | NANO CAP NEW MILLENNIUM GROWTH FUND L P | 50.0K +50.0K (+100.0%) | 894.00M +894.0M (+100.0%) | 0.07% +0.068 pp | 0.76% +0.763 pp | USD17.88 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 9.52M -44.0K (-0.5%) | 170.17M -21.6M (-11.3%) | 12.93% -0.093 pp | 0.00% -0.001 pp | USD18.78 -4.8% | 6 qtrs — |
| 3 | BILL & MELINDA GATES FOUNDATION TRUST | 6.98M +— (+0.0%) | 124.83M -15.2M (-10.9%) | 9.48% -0.024 pp | 0.35% -0.030 pp | USD53.45 -66.5% | 24 qtrs — |
| 4 | VANGUARD GROUP INC | 6.46M +125.3K (+2.0%) | 115.58M -11.6M (-9.1%) | 8.78% +0.149 pp | 0.00% 0.000 pp | USD54.38 -67.1% | 24 qtrs — |
| 5 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 4.71M +160.2K (+3.5%) | 84.30M -7.1M (-7.7%) | 6.40% +0.202 pp | 0.05% -0.003 pp | USD24.78 -27.8% | 23 qtrs — |
| 6 | RUBRIC CAPITAL MANAGEMENT LP | 4.17M -1.1M (-20.8%) | 74.59M -31.1M (-29.4%) | 5.67% -1.509 pp | 0.89% -0.301 pp | USD20.36 -12.2% | 8 qtrs — |
| 7 | UBS ASSET MANAGEMENT AMERICAS INC | 3.72M +414.2K (+12.5%) | 66.48M +204.5K (+0.3%) | 5.05% +0.551 pp | 0.01% 0.000 pp | USD19.63 -8.9% | 23 qtrs — |
| 8 | NIKKO ASSET MANAGEMENT AMERICAS, INC. | 2.82M +180.7K (+6.8%) | 50.36M -2.6M (-4.9%) | 3.83% +0.237 pp | 0.58% +0.069 pp | USD22.97 -22.2% | 23 qtrs — |
| 9 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.29M +218.9K (+10.6%) | 40.97M -603.7K (-1.5%) | 3.11% +0.290 pp | 0.01% +0.000 pp | USD20.75 -13.8% | 8 qtrs — |
| 10 | STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 2.25M +57.1K (+2.6%) | 40.23M -3.8M (-8.5%) | 3.06% +0.070 pp | 0.52% -0.046 pp | USD27.95 -36.0% | 21 qtrs — |
| 11 | LAZARD ASSET MANAGEMENT LLC | 2.13M -211.5K (-9.0%) | 38.17M -8.9M (-18.9%) | 2.90% -0.295 pp | 0.06% +0.001 pp | USD26.60 -32.8% | 21 qtrs — |
| 12 | STATE STREET CORP | 2.13M -73.1K (-3.3%) | 38.12M -6.1M (-13.8%) | 2.90% -0.107 pp | 0.00% 0.000 pp | USD45.98 -61.1% | 24 qtrs — |
| 13 | ARK INVESTMENT MANAGEMENT LLC | 2.11M +239.2K (+12.8%) | 37.76M +193.6K (+0.5%) | 2.87% +0.319 pp | 0.25% +0.027 pp | USD47.84 -62.6% | 23 qtrs — |
| 14 | UBS GROUP AG | 1.44M +489.1K (+51.3%) | 25.80M +6.7M (+34.8%) | 1.96% +0.661 pp | 0.00% +0.001 pp | USD19.43 -8.0% | 24 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 1.38M +108.0K (+8.5%) | 24.76M -851.4K (-3.3%) | 1.88% +0.142 pp | 0.00% 0.000 pp | USD46.23 -61.3% | 24 qtrs — |
| 16 | PEAK6 LLC | 1.36M +265.2K (+24.3%) | 24.28M +2.4M (+10.8%) | 1.84% +0.357 pp | 0.05% +0.013 pp | USD19.63 -8.9% | 5 qtrs — |
| 17 | MORGAN STANLEY | 1.19M -550.7K (-31.7%) | 21.22M -13.6M (-39.1%) | 1.61% -0.754 pp | 0.00% -0.001 pp | USD39.54 -54.8% | 24 qtrs — |
| 18 | AMERICAN CENTURY COMPANIES INC | 1.11M +22.2K (+2.0%) | 19.81M -2.0M (-9.0%) | 1.50% +0.027 pp | 0.01% -0.001 pp | USD19.73 -9.4% | 4 qtrs — |
| 19 | DIMENSIONAL FUND ADVISORS LP | 1.01M +161.2K (+18.9%) | 18.11M +1.0M (+6.0%) | 1.38% +0.216 pp | 0.00% +0.000 pp | USD26.08 -31.4% | 22 qtrs — |
| 20 | MILLENNIUM MANAGEMENT LLC | 978.2K -573.5K (-37.0%) | 17.49M -13.6M (-43.8%) | 1.33% -0.785 pp | 0.01% -0.006 pp | USD19.99 -10.6% | 24 qtrs — |
| 21 | BAILLIE GIFFORD & CO | 835.5K -139.3K (-14.3%) | 14.94M -4.6M (-23.6%) | 1.14% -0.193 pp | 0.01% -0.002 pp | USD33.18 -46.1% | 21 qtrs — |
| 22 | GOLDMAN SACHS GROUP INC | 669.5K +107.3K (+19.1%) | 11.97M +693.9K (+6.2%) | 0.91% +0.144 pp | 0.00% +0.000 pp | USD21.78 -17.9% | 24 qtrs — |
| 23 | NORTHERN TRUST CORP | 555.4K -30.6K (-5.2%) | 9.93M -1.8M (-15.5%) | 0.75% -0.044 pp | 0.00% 0.000 pp | USD46.92 -61.9% | 24 qtrs — |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 515.9K +30.4K (+6.3%) | 9.22M -513.9K (-5.3%) | 0.70% +0.040 pp | 0.00% 0.000 pp | USD48.06 -62.8% | 24 qtrs — |
| 25 | TWO SIGMA ADVISERS, LP | 506.6K -234.5K (-31.6%) | 9.06M -5.8M (-39.1%) | 0.69% -0.321 pp | 0.02% -0.012 pp | USD20.04 -10.8% | 5 qtrs — |
| 26 | MAN GROUP PLC | 441.4K +278.2K (+170.5%) | 7.89M +4.6M (+141.1%) | 0.60% +0.377 pp | 0.01% +0.008 pp | USD18.69 -4.3% | 3 qtrs — |
| 27 | TUDOR INVESTMENT CORP ET AL | 438.9K +102.5K (+30.5%) | 7.85M +1.1M (+16.3%) | 0.60% +0.138 pp | 0.01% +0.003 pp | USD19.59 -8.7% | 22 qtrs — |
| 28 | TWO SIGMA INVESTMENTS, LP | 436.8K -354.3K (-44.8%) | 7.81M -8.1M (-50.8%) | 0.59% -0.484 pp | 0.01% -0.013 pp | USD19.95 -10.4% | 5 qtrs — |
| 29 | BANK OF NEW YORK MELLON CORP | 310.6K -28.7K (-8.5%) | 5.55M -1.3M (-18.4%) | 0.42% -0.040 pp | 0.00% 0.000 pp | USD48.01 -62.8% | 24 qtrs — |
| 30 | PARKMAN HEALTHCARE PARTNERS LLC | 298.9K -41.2K (-12.1%) | 5.35M -1.5M (-21.7%) | 0.41% -0.057 pp | 0.51% -0.203 pp | USD27.44 -34.8% | 24 qtrs — |
| 31 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 273.3K +185.6K (+211.9%) | 4.89M +3.1M (+178.0%) | 0.37% +0.252 pp | 0.01% +0.007 pp | USD18.58 -3.8% | 2 qtrs — |
| 32 | FRED ALGER MANAGEMENT, LLC | 269.8K +166.7K (+161.7%) | 4.82M +2.8M (+133.2%) | 0.37% +0.226 pp | 0.02% +0.011 pp | USD18.72 -4.5% | 3 qtrs — |
| 33 | PRINCIPAL FINANCIAL GROUP INC | 268.4K -2.8K (-1.0%) | 4.80M -640.7K (-11.8%) | 0.36% -0.005 pp | 0.00% 0.000 pp | USD48.25 -62.9% | 11 qtrs — |
| 34 | ALLIANZ ASSET MANAGEMENT GMBH | 248.1K +248.1K (+100.0%) | 4.44M +4.4M (+100.0%) | 0.34% +0.337 pp | 0.00% +0.005 pp | USD17.88 +0.0% | 1 qtrs NEW |
| 35 | JUPITER ASSET MANAGEMENT LTD | 223.9K -10.7K (-4.6%) | 4.00M -703.4K (-14.9%) | 0.30% -0.015 pp | 0.03% -0.008 pp | USD20.06 -10.9% | 2 qtrs — |
| 36 | ALGERT GLOBAL LLC | 211.4K +177.5K (+523.9%) | 3.78M +3.1M (+455.9%) | 0.29% +0.241 pp | 0.06% +0.048 pp | USD18.25 -2.0% | 8 qtrs — |
| 37 | PERCEPTIVE ADVISORS LLC | 202.4K +202.4K (+100.0%) | 3.62M +3.6M (+100.0%) | 0.28% +0.275 pp | 0.06% +0.065 pp | USD17.88 +0.0% | 1 qtrs NEW |
| 38 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 198.4K +52.2K (+35.7%) | 3.55M +614.6K (+21.0%) | 0.27% +0.070 pp | 0.00% +0.000 pp | USD27.55 -35.1% | 24 qtrs — |
| 39 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 194.3K -24.4K (-11.1%) | 3.47M -912.4K (-20.8%) | 0.26% -0.034 pp | 0.01% -0.004 pp | USD31.83 -43.8% | 11 qtrs — |
| 40 | INVESCO LTD. | 190.8K +10.3K (+5.7%) | 3.41M -209.1K (-5.8%) | 0.26% +0.013 pp | 0.00% +0.000 pp | USD39.93 -55.2% | 21 qtrs — |
| 41 | CITADEL ADVISORS LLC | 187.9K -98.4K (-34.4%) | 3.36M -2.4M (-41.5%) | 0.26% -0.135 pp | 0.00% 0.000 pp | USD20.19 -11.4% | 24 qtrs — |
| 42 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 185.0K -14.4K (-7.2%) | 3.31M -691.4K (-17.3%) | 0.25% -0.020 pp | 0.01% -0.001 pp | USD29.13 -38.6% | 17 qtrs — |
| 43 | HRT FINANCIAL LP | 164.6K +118.2K (+254.5%) | 2.94M +2.0M (+216.0%) | 0.22% +0.160 pp | 0.01% +0.006 pp | USD18.49 -3.3% | 6 qtrs — |
| 44 | AQR CAPITAL MANAGEMENT LLC | 161.7K +126.3K (+356.6%) | 2.89M +2.2M (+307.0%) | 0.22% +0.172 pp | 0.00% +0.001 pp | USD18.36 -2.6% | 3 qtrs — |
| 45 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 158.2K +129.9K (+459.2%) | 2.83M +2.3M (+398.4%) | 0.21% +0.176 pp | 0.04% +0.035 pp | USD18.28 -2.2% | 3 qtrs — |
| 46 | TOCQUEVILLE ASSET MANAGEMENT L.P. | 157.0K -15.3K (-8.9%) | 2.81M -648.2K (-18.8%) | 0.21% -0.021 pp | 0.04% -0.009 pp | USD24.86 -28.1% | 17 qtrs — |
| 47 | RHUMBLINE ADVISERS | 154.5K -11.5K (-6.9%) | 2.76M -567.0K (-17.0%) | 0.21% -0.016 pp | 0.00% 0.000 pp | USD45.94 -61.1% | 24 qtrs — |
| 48 | FMR LLC | 151.3K -46.4K (-23.5%) | 2.71M -1.3M (-31.8%) | 0.21% -0.064 pp | 0.00% 0.000 pp | USD36.10 -50.5% | 24 qtrs — |
| 49 | LEGAL & GENERAL GROUP PLC | 147.7K -9.0K (-5.7%) | 2.64M -502.2K (-16.0%) | 0.20% -0.013 pp | 0.00% 0.000 pp | USD49.48 -63.9% | 24 qtrs — |
| 50 | FIRST TRUST ADVISORS LP | 136.9K -26.5K (-16.2%) | 2.45M -830.1K (-25.3%) | 0.19% -0.037 pp | 0.00% -0.001 pp | USD20.08 -11.0% | 3 qtrs — |
| 51 | TREXQUANT INVESTMENT LP | 135.0K +135.0K (+100.0%) | 2.41M +2.4M (+100.0%) | 0.18% +0.183 pp | 0.02% +0.022 pp | USD17.88 +0.0% | 1 qtrs NEW |
| 52 | SLOW CAPITAL, INC. | 131.3K +37.4K (+39.8%) | 2.35M +463.6K (+24.6%) | 0.18% +0.050 pp | 0.28% +0.059 pp | USD19.48 -8.2% | 3 qtrs — |
| 53 | BANK OF AMERICA CORP /DE/ | 130.9K -67.8K (-34.1%) | 2.34M -1.6M (-41.3%) | 0.18% -0.093 pp | 0.00% 0.000 pp | USD21.09 -15.2% | 24 qtrs — |
| 54 | SWISS NATIONAL BANK | 127.2K +2.8K (+2.3%) | 2.27M -221.1K (-8.9%) | 0.17% +0.003 pp | 0.00% 0.000 pp | USD62.41 -71.4% | 23 qtrs — |
| 55 | NUVEEN, LLC | 125.0K -58.4K (-31.9%) | 2.24M -1.4M (-39.3%) | 0.17% -0.080 pp | 0.00% 0.000 pp | USD19.83 -9.8% | 4 qtrs — |
| 56 | TEJARA CAPITAL LTD | 121.7K -8.0K (-6.2%) | 2.18M -425.8K (-16.4%) | 0.17% -0.011 pp | 0.51% -0.845 pp | USD19.32 -7.5% | 7 qtrs — |
| 57 | BNP PARIBAS ARBITRAGE, SNC | 118.7K +68.4K (+135.8%) | 2.12M +1.1M (+110.2%) | 0.16% +0.093 pp | 0.00% +0.000 pp | USD18.68 -4.3% | 5 qtrs — |
| 58 | WELLS FARGO & COMPANY/MN | 112.5K +15.3K (+15.8%) | 2.01M +62.0K (+3.2%) | 0.15% +0.021 pp | 0.00% +0.000 pp | USD23.25 -23.1% | 24 qtrs — |
| 59 | BARCLAYS PLC | 111.4K +3.8K (+3.5%) | 1.99M -3.8K (-0.2%) | 0.15% +0.005 pp | 0.00% +0.000 pp | USD20.72 -13.7% | 16 qtrs — |
| 60 | CITIGROUP INC | 109.4K -45.8K (-29.5%) | 1.96M -1.2M (-37.2%) | 0.15% -0.063 pp | 0.00% -0.001 pp | USD21.48 -16.8% | 24 qtrs — |
| 61 | AMERIPRISE FINANCIAL INC | 102.7K -7.8K (-7.0%) | 1.84M -380.0K (-17.1%) | 0.14% -0.011 pp | 0.00% 0.000 pp | USD27.08 -34.0% | 24 qtrs — |
| 62 | MARSHALL WACE, LLP | 80.8K +42.3K (+109.9%) | 1.44M +672.2K (+87.1%) | 0.11% +0.057 pp | 0.00% +0.001 pp | USD18.95 -5.6% | 6 qtrs — |
| 63 | JPMORGAN CHASE & CO | 79.7K -1.6K (-2.0%) | 1.42M -205.9K (-12.6%) | 0.11% -0.003 pp | 0.00% +0.000 pp | USD52.42 -65.9% | 24 qtrs — |
| 64 | CAPITAL FUND MANAGEMENT S.A. | 73.0K +40.8K (+126.7%) | 1.30M +659.1K (+102.1%) | 0.10% +0.055 pp | 0.00% +0.002 pp | USD18.87 -5.2% | 3 qtrs — |
| 65 | FARALLON CAPITAL MANAGEMENT LLC | 71.0K -213.0K (-75.0%) | 1.27M -4.4M (-77.7%) | 0.10% -0.290 pp | 0.01% -0.017 pp | USD20.12 -11.1% | 3 qtrs — |
| 66 | IQ EQ FUND MANAGEMENT (IRELAND) LTD | 68.8K +27.4K (+66.2%) | 1.23M +399.4K (+48.1%) | 0.09% +0.037 pp | 0.08% +0.029 pp | USD19.11 -6.4% | 4 qtrs — |
| 67 | ALLIANCEBERNSTEIN L.P. | 68.7K -3.3K (-4.6%) | 1.23M -215.8K (-14.9%) | 0.09% -0.005 pp | 0.00% 0.000 pp | USD38.08 -53.0% | 24 qtrs — |
| 68 | VERITY ASSET MANAGEMENT, INC. | 65.7K +798.0 (+1.2%) | 1.18M -127.3K (-9.8%) | 0.09% +0.001 pp | 0.50% +0.079 pp | USD20.07 -10.9% | 3 qtrs — |
| 69 | SCHONFELD STRATEGIC ADVISORS LLC | 65.6K +39.2K (+148.6%) | 1.17M +643.9K (+121.5%) | 0.09% +0.053 pp | 0.01% +0.002 pp | USD19.14 -6.6% | 14 qtrs — |
| 70 | ENGINEERS GATE MANAGER LP | 65.4K +52.0K (+389.4%) | 1.17M +901.3K (+336.2%) | 0.09% +0.071 pp | 0.01% +0.011 pp | USD18.30 -2.3% | 10 qtrs — |
| 71 | SG AMERICAS SECURITIES, LLC | 65.2K +27.0K (+70.9%) | 1.17M +400.0K (+52.3%) | 0.09% +0.037 pp | 0.00% -0.001 pp | USD18.98 -5.8% | 6 qtrs — |
| 72 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 62.5K +62.5K (+100.0%) | 1.12M +1.1M (+100.0%) | 0.08% +0.085 pp | 0.01% +0.009 pp | USD17.88 +0.0% | 5 qtrs — |
| 73 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 61.6K +3.2K (+5.5%) | 1.10M -69.8K (-6.0%) | 0.08% +0.004 pp | 0.00% 0.000 pp | USD47.53 -62.4% | 24 qtrs — |
| 74 | PRICE T ROWE ASSOCIATES INC /MD/ | 60.9K +7.9K (+14.9%) | 1.09M +26.0K (+2.4%) | 0.08% +0.011 pp | 0.00% +0.000 pp | USD29.02 -38.4% | 24 qtrs — |
| 75 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 54.7K -3.4K (-5.8%) | 978.5K -187.3K (-16.1%) | 0.07% -0.005 pp | 0.00% 0.000 pp | USD19.37 -7.7% | 7 qtrs — |
| 76 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 52.9K -13.7K (-20.5%) | 944.0K -388.0K (-29.1%) | 0.07% -0.019 pp | 0.00% 0.000 pp | USD39.28 -54.5% | 23 qtrs — |
| 77 | PRUDENTIAL FINANCIAL INC | 52.5K -3.8K (-6.7%) | 938.9K -190.3K (-16.9%) | 0.07% -0.005 pp | 0.00% 0.000 pp | USD48.11 -62.8% | 11 qtrs — |
| 78 | QUBE RESEARCH & TECHNOLOGIES LTD | 52.1K -12.2K (-19.0%) | 931.4K -359.0K (-27.8%) | 0.07% -0.017 pp | 0.00% 0.000 pp | USD20.12 -11.1% | 3 qtrs — |
| 79 | ROYAL BANK OF CANADA | 51.6K -377.3K (-88.0%) | 922.0K -7.7M (-89.3%) | 0.07% -0.514 pp | 0.00% -0.001 pp | USD21.20 -15.7% | 24 qtrs — |
| 80 | PIER 88 INVESTMENT PARTNERS LLC | 50.9K -3.3K (-6.1%) | 909.6K -177.5K (-16.3%) | 0.07% -0.005 pp | 0.20% -0.001 pp | USD20.09 -11.0% | 8 qtrs — |
| 81 | LPL FINANCIAL LLC | 50.7K -199.0 (-0.4%) | 906.7K -114.5K (-11.2%) | 0.07% 0.000 pp | 0.00% 0.000 pp | USD30.21 -40.8% | 23 qtrs — |
| 82 | KESTRA ADVISORY SERVICES, LLC | 50.4K +9.0K (+21.6%) | 901.6K +69.9K (+8.4%) | 0.07% +0.012 pp | 0.00% 0.000 pp | USD19.67 -9.1% | 2 qtrs — |
| 83 | FOX RUN MANAGEMENT, L.L.C. | 47.8K +30.0K (+168.9%) | 855.2K +498.4K (+139.7%) | 0.07% +0.041 pp | 0.13% +0.076 pp | USD18.69 -4.3% | 2 qtrs — |
| 84 | WESBANCO BANK INC | 46.9K +46.9K (+100.0%) | 838.6K +838.6K (+100.0%) | 0.06% +0.064 pp | 0.02% +0.023 pp | USD17.88 +0.0% | 1 qtrs NEW |
| 85 | DEUTSCHE BANK AG\ | 46.3K +4.3K (+10.2%) | 828.4K -15.3K (-1.8%) | 0.06% +0.006 pp | 0.00% +0.000 pp | USD30.75 -41.9% | 24 qtrs — |
| 86 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 45.9K +— (+0.0%) | 821.0K -100.0K (-10.9%) | 0.06% 0.000 pp | 0.00% 0.000 pp | USD45.01 -60.3% | 11 qtrs — |
| 87 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 44.6K +15.2K (+51.6%) | 797.3K +207.3K (+35.1%) | 0.06% +0.021 pp | 0.01% +0.006 pp | USD19.26 -7.2% | 5 qtrs — |
| 88 | ENTRYPOINT CAPITAL, LLC | 44.3K +28.9K (+187.9%) | 792.4K +483.6K (+156.6%) | 0.06% +0.039 pp | 0.31% +0.190 pp | USD18.64 -4.1% | 2 qtrs — |
| 89 | STIFEL FINANCIAL CORP | 40.4K -4.9K (-10.8%) | 722.5K -186.0K (-20.5%) | 0.05% -0.007 pp | 0.00% 0.000 pp | USD19.61 -8.8% | 7 qtrs — |
| 90 | SEI INVESTMENTS CO | 39.1K +8.2K (+26.7%) | 699.8K +80.0K (+12.9%) | 0.05% +0.011 pp | 0.00% +0.000 pp | USD19.09 -6.3% | 11 qtrs — |
| 91 | THRIVENT FINANCIAL FOR LUTHERANS | 38.6K -1.9K (-4.7%) | 689.0K -122.0K (-15.0%) | 0.05% -0.003 pp | 0.00% 0.000 pp | USD49.65 -64.0% | 11 qtrs — |
| 92 | AQUATIC CAPITAL MANAGEMENT LLC | 38.1K +38.1K (+100.0%) | 680.5K +680.5K (+100.0%) | 0.05% +0.052 pp | 0.02% +0.019 pp | USD17.88 +0.0% | 1 qtrs NEW |
| 93 | STATE OF WISCONSIN INVESTMENT BOARD | 37.9K -3.2K (-7.9%) | 677.0K -147.3K (-17.9%) | 0.05% -0.005 pp | 0.00% 0.000 pp | USD52.65 -66.0% | 19 qtrs — |
| 94 | POINT72 ASSET MANAGEMENT, L.P. | 37.4K +37.4K (+100.0%) | 668.4K +668.4K (+100.0%) | 0.05% +0.051 pp | 0.00% +0.001 pp | USD17.88 +0.0% | 1 qtrs NEW |
| 95 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 34.0K +34.0K (+100.0%) | 607.7K +607.7K (+100.0%) | 0.05% +0.046 pp | 0.01% +0.008 pp | USD17.88 +0.0% | 1 qtrs NEW |
| 96 | JANE STREET GROUP, LLC | 33.5K -13.4K (-28.6%) | 599.0K -341.8K (-36.3%) | 0.05% -0.018 pp | 0.00% 0.000 pp | USD19.92 -10.2% | 4 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 115 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | TrueShares Technology, AI and Deep Learning ETF LRNZ | 2.96% | 1.21M | 0.68% |
| 2 | ARK Genomic Revolution ETF ARKG | 1.99% | 25.96M | 0.75% |
| 3 | Spear Alpha ETF SPRX | 1.96% | 5.07M | 0.75% |
| 4 | Global X HealthTech ETF HEAL | 0.90% | 269.8K | 0.50% |
| 5 | Invesco S&P SmallCap Health Care ETF PSCH | 0.41% | 672.0K | 0.29% |
| 6 | Harbor Human Capital Factor US Small Cap ETF HAPS | 0.15% | 264.6K | 0.61% |
| 7 | iShares U.S. Healthcare Providers ETF IHF | 0.14% | 1.64M | 0.38% |
| 8 | JPMorgan Small & Mid Cap Enhanced Equity ETF JMEE | 0.12% | 3.31M | 0.24% |
| 9 | iShares Healthcare Innovation UCITS ETF HEAL.L | 0.11% | 1.24M | 0.40% |
| 10 | iShares S&P Small-Cap 600 Growth ETF IJT | 0.10% | 8.74M | 0.18% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.33
Bearish
Ratio by volume
0.48
Bearish
Buys
2
Sells
6
Shares acquired
117.5K
Shares disposed
247.4K
Cash buys
—
Cash sales
3.00
Net activity
-129,844
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | Farid Ramy | Director / Officer | M-Exempt | A | Common Stock | 74,527 | 3.07 | 228.8K | 405,351 | D | ↗ |
| 2026-04-16 | Jain Rachit | Officer | S-Sale | D | Common Stock | 844 | 12.75 | 10.8K | 51,752 | D | ↗ |
| 2026-04-16 | Farid Ramy | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 43,000 | 3.07 | 132.0K | 117,527 | D | ↗ |
| 2026-03-08 | Abrams Therese Marie | Officer | — | — | Stock Option (right to buy) | 5,526 | 21.24 | 117.4K | 0 | D | ↗ |
| 2026-03-06 | Herman Jenny | Officer | S-Sale | D | Common Stock | 608 | 12.84 | 7.8K | 34,804 | D | ↗ |
| 2026-03-05 | Tran Yvonne | Officer | S-Sale | D | Common Stock | 1,094 | 12.90 | 14.1K | 52,683 | D | ↗ |
| 2026-03-05 | Lorton Kenneth Patrick | Officer | S-Sale | D | Common Stock | 1,222 | 12.90 | 15.8K | 89,241 | D | ↗ |
| 2026-03-05 | Jain Rachit | Officer | S-Sale | D | Common Stock | 1,631 | 12.90 | 21.0K | 52,596 | D | ↗ |
| 2026-03-05 | Herman Jenny | Officer | S-Sale | D | Common Stock | 775 | 12.85 | 10.0K | 35,412 | D | ↗ |
| 2026-03-05 | Farid Ramy | Director / Officer | S-Sale | D | Common Stock | 3,661 | 12.91 | 47.2K | 330,824 | D | ↗ |
| 2026-03-05 | Akinsanya Karen | Officer | S-Sale | D | Common Stock | 1,366 | 12.90 | 17.6K | 69,956 | D | ↗ |
| 2026-03-04 | Abel Robert Lorne | Officer | S-Sale | D | Common Stock | 1,300 | 12.81 | 16.7K | 55,897 | D | ↗ |
| 2026-02-10 | Tran Yvonne | Officer | S-Sale | D | Common Stock | 776 | 13.80 | 10.7K | 22,859 | D | ↗ |
| 2026-02-10 | Lorton Kenneth Patrick | Officer | S-Sale | D | Common Stock | 925 | 13.73 | 12.7K | 52,651 | D | ↗ |
| 2026-02-10 | Herman Jenny | Officer | S-Sale | D | Common Stock | 752 | 13.79 | 10.4K | 26,597 | D | ↗ |
| 2026-02-09 | Abel Robert Lorne | Officer | S-Sale | D | Common Stock | 1,230 | 13.51 | 16.6K | 19,385 | D | ↗ |
| 2025-10-16 | Dugan Margaret | Officer | S-Sale | D | Common Stock | 1,395 | 21.07 | 29.4K | 24,574 | D | ↗ |
| 2025-06-18 | van Kralingen Bridget A | Director | A-Award | A | Stock Option (right to buy) | 2,335 | 21.05 | 49.2K | 2,335 | D | ↗ |
| 2025-06-18 | Thornberry Nancy | Director | A-Award | A | Stock Option (right to buy) | 9,341 | 21.05 | 196.6K | 9,341 | D | ↗ |
| 2025-06-18 | Sender Gary | Director | A-Award | A | Stock Option (right to buy) | 9,341 | 21.05 | 196.6K | 9,341 | D | ↗ |
| 2025-06-18 | OBEROI ARUN | Director | A-Award | A | Stock Option (right to buy) | 9,341 | 21.05 | 196.6K | 9,341 | D | ↗ |
| 2025-06-18 | Lynton Michael | Director | A-Award | A | Stock Option (right to buy) | 9,341 | 21.05 | 196.6K | 9,341 | D | ↗ |
| 2025-06-18 | Kapeller-Libermann Rosana | Director | A-Award | A | Stock Option (right to buy) | 9,341 | 21.05 | 196.6K | 9,341 | D | ↗ |
| 2025-06-18 | GINSBERG GARY L | Director | A-Award | A | Stock Option (right to buy) | 9,341 | 21.05 | 196.6K | 9,341 | D | ↗ |
| 2025-06-18 | Friesner Richard | Director | A-Award | A | Stock Option (right to buy) | 9,341 | 21.05 | 196.6K | 9,341 | D | ↗ |
| 2025-06-18 | Chodakewitz Jeffrey | Director | A-Award | A | Stock Option (right to buy) | 9,341 | 21.05 | 196.6K | 9,341 | D | ↗ |
| 2025-05-29 | Aklian Mannix Vartan | Officer | A-Award | A | Stock Option (right to buy) | 84,375 | 21.44 | 1.81M | 84,375 | D | ↗ |
| 2025-05-28 | Aklian Mannix Vartan | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-05-21 | Jain Rachit | Officer | A-Award | A | Common Stock | 9,375 | 0.00 | — | 37,097 | D | ↗ |
| 2025-05-16 | Jain Rachit | Officer | — | — | Common Stock | 0 | 0.00 | — | 27,722 | D | ↗ |
| 2025-04-14 | Akinsanya Karen | Officer | S-Sale | D | Common Stock | 5,000 | 25.11 | 125.6K | 18,970 | D | ↗ |
| 2025-03-07 | van Kralingen Bridget A | Director | A-Award | A | Stock Option (right to buy) | 17,050 | 21.02 | 358.4K | 17,050 | D | ↗ |
| 2025-03-06 | Herman Jenny | Officer | S-Sale | D | Common Stock | 666 | 21.11 | 14.1K | 27,349 | D | ↗ |
| 2025-03-03 | Tran Yvonne | Officer | A-Award | A | Common Stock | 12,500 | 0.00 | — | 23,635 | D | ↗ |
| 2025-03-03 | Porges Geoffrey Craig | Officer | A-Award | A | Common Stock | 12,500 | 0.00 | — | 18,185 | D | ↗ |
| 2025-03-03 | Lorton Kenneth Patrick | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 21.24 | 1.06M | 50,000 | D | ↗ |
| 2025-03-03 | Herman Jenny | Officer | A-Award | A | Stock Option (right to buy) | 8,400 | 21.24 | 178.4K | 8,400 | D | ↗ |
| 2025-03-03 | Farid Ramy | Director / Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 21.24 | 1.27M | 60,000 | D | ↗ |
| 2025-03-03 | Dugan Margaret | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 21.24 | 1.06M | 50,000 | D | ↗ |
| 2025-03-03 | Akinsanya Karen | Officer | A-Award | A | Common Stock | 15,625 | 0.00 | — | 15,625 | D | ↗ |
| 2025-03-03 | Abel Robert Lorne | Officer | A-Award | A | Common Stock | 12,500 | 0.00 | — | 20,615 | D | ↗ |
| 2025-02-18 | Tran Yvonne | Officer | M-Exempt | A | Common Stock | 3,902 | 4.34 | 16.9K | 15,037 | D | ↗ |
| 2025-02-11 | Tran Yvonne | Officer | S-Sale | D | Common Stock | 828 | 24.43 | 20.2K | 11,135 | D | ↗ |
| 2025-02-11 | Lorton Kenneth Patrick | Officer | S-Sale | D | Common Stock | 985 | 24.43 | 24.1K | 41,076 | D | ↗ |
| 2025-02-11 | Herman Jenny | Officer | S-Sale | D | Common Stock | 859 | 24.43 | 21.0K | 18,215 | D | ↗ |
| 2025-02-10 | Abel Robert Lorne | Officer | S-Sale | D | Common Stock | 1,225 | 25.99 | 31.8K | 8,115 | D | ↗ |
| 2024-10-15 | Dugan Margaret | Officer | S-Sale | D | Common Stock | 1,531 | 17.78 | 27.2K | 13,469 | D | ↗ |
| 2024-06-18 | Thornberry Nancy | Director | A-Award | A | Stock Option (right to buy) | 8,550 | 19.32 | 165.2K | 8,550 | — | ↗ |
| 2024-06-18 | Sender Gary | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 11,250 | — | ↗ |
| 2024-06-18 | OBEROI ARUN | Director | A-Award | A | Stock Option (right to buy) | 8,550 | 19.32 | 165.2K | 8,550 | — | ↗ |
| 2024-06-18 | Lynton Michael | Director | A-Award | A | Stock Option (right to buy) | 8,550 | 19.32 | 165.2K | 8,550 | — | ↗ |
| 2024-06-18 | Kapeller-Libermann Rosana | Director | A-Award | A | Stock Option (right to buy) | 8,550 | 19.32 | 165.2K | 8,550 | — | ↗ |
| 2024-06-18 | GINSBERG GARY L | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 11,250 | — | ↗ |
| 2024-06-18 | Friesner Richard | Director | A-Award | A | Stock Option (right to buy) | 8,550 | 19.32 | 165.2K | 8,550 | — | ↗ |
| 2024-06-18 | Chodakewitz Jeffrey | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 11,250 | — | ↗ |
| 2024-03-21 | Lorton Kenneth Patrick | Officer | A-Award | A | Stock Option (right to buy) | 30,000 | 27.51 | 825.3K | 30,000 | — | ↗ |
| 2024-03-21 | Abel Robert Lorne | Officer | A-Award | A | Stock Option (right to buy) | 30,000 | 27.51 | 825.3K | 30,000 | — | ↗ |
| 2024-03-06 | Lorton Kenneth Patrick | Officer | M-Exempt | A | Common Stock | 5,574 | 4.34 | 24.2K | 42,061 | — | ↗ |
| 2024-03-04 | Tran Yvonne | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 25.24 | 1.51M | 60,000 | — | ↗ |
| 2024-03-04 | Porges Geoffrey Craig | Officer | A-Award | A | Stock Option (right to buy) | 90,000 | 25.24 | 2.27M | 90,000 | — | ↗ |
| 2024-03-04 | Lorton Kenneth Patrick | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 25.24 | 1.51M | 60,000 | — | ↗ |
| 2024-03-04 | Herman Jenny | Officer | A-Award | A | Common Stock | 7,313 | 0.00 | — | 19,074 | — | ↗ |
| 2024-03-04 | Farid Ramy | Director / Officer | A-Award | A | Stock Option (right to buy) | 126,000 | 25.24 | 3.18M | 126,000 | — | ↗ |
| 2024-03-04 | Dugan Margaret | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 25.24 | 1.51M | 60,000 | — | ↗ |
| 2024-03-04 | Akinsanya Karen | Officer | A-Award | A | Stock Option (right to buy) | 120,000 | 25.24 | 3.03M | 120,000 | — | ↗ |
| 2024-03-04 | Abel Robert Lorne | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 25.24 | 1.51M | 60,000 | — | ↗ |
| 2024-02-12 | Tran Yvonne | Officer | S-Sale | D | Common Stock | 758 | 28.29 | 21.4K | 11,963 | — | ↗ |
| 2024-02-12 | Lorton Kenneth Patrick | Officer | S-Sale | D | Common Stock | 901 | 28.29 | 25.5K | 36,487 | — | ↗ |
| 2024-02-12 | Herman Jenny | Officer | S-Sale | D | Common Stock | 787 | 28.29 | 22.3K | 11,761 | — | ↗ |
| 2024-02-12 | Abel Robert Lorne | Officer | S-Sale | D | Common Stock | 1,205 | 27.55 | 33.2K | 9,340 | — | ↗ |
| 2023-09-15 | Herman Jenny | Officer | M-Exempt | A | Common Stock | 4,545 | 1.20 | 5.5K | 12,548 | — | ↗ |
| 2023-08-09 | Lorton Kenneth Patrick | Officer | S-Sale | D | Common Stock | 10,000 | 40.06 | 400.6K | 37,388 | — | ↗ |
| 2023-08-09 | Dugan Margaret | Officer | A-Award | A | Stock Option (right to buy) | 90,000 | 39.89 | 3.59M | 90,000 | — | ↗ |
| 2023-07-31 | Dugan Margaret | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-30 | Tran Yvonne | Officer | M-Exempt | D | Stock Option (right to buy) | 12,040 | 17.00 | 204.7K | 188,619 | — | ↗ |
| 2023-06-15 | Thornberry Nancy | Director | A-Award | A | Common Stock | 6,250 | 0.00 | — | 6,250 | — | ↗ |
| 2023-06-15 | Sender Gary | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 45.26 | 565.8K | 12,500 | — | ↗ |
| 2023-06-15 | OBEROI ARUN | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 45.26 | 565.8K | 12,500 | — | ↗ |
| 2023-06-15 | Lynton Michael | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 45.26 | 565.8K | 12,500 | — | ↗ |
| 2023-06-15 | Kapeller-Libermann Rosana | Director | A-Award | A | Common Stock | 6,250 | 0.00 | — | 6,250 | — | ↗ |
| 2023-06-15 | GINSBERG GARY L | Director | A-Award | A | Stock Option (right to buy) | 12,500 | 45.26 | 565.8K | 12,500 | — | ↗ |
| 2023-06-15 | Friesner Richard | Director | A-Award | A | Common Stock | 6,250 | 0.00 | — | 510,700 | — | ↗ |
| 2023-06-15 | Chodakewitz Jeffrey | Director | A-Award | A | Common Stock | 6,250 | 0.00 | — | 6,250 | — | ↗ |
| 2023-05-23 | Tran Yvonne | Officer | S-Sale | D | Common Stock | 7,960 | 40.01 | 318.5K | 12,721 | — | ↗ |
| 2023-05-23 | Lorton Kenneth Patrick | Officer | S-Sale | D | Common Stock | 10,000 | 40.06 | 400.6K | 47,388 | — | ↗ |
| 2023-05-22 | Tran Yvonne | Officer | M-Exempt | A | Common Stock | 108 | 3.07 | 331.56 | 12,829 | — | ↗ |
| 2023-05-22 | Thornberry Nancy | Director | M-Exempt | D | Stock Option (right to buy) | 14,850 | 11.52 | 171.1K | 27,020 | — | ↗ |
| 2023-02-09 | Tran Yvonne | Officer | A-Award | A | Common Stock | 7,590 | 0.00 | — | 12,721 | — | ↗ |
| 2023-02-09 | Porges Geoffrey Craig | Officer | A-Award | A | Stock Option (right to buy) | 54,735 | 23.29 | 1.27M | 54,735 | — | ↗ |
| 2023-02-09 | Lorton Kenneth Patrick | Officer | A-Award | A | Stock Option (right to buy) | 49,000 | 23.29 | 1.14M | 49,000 | — | ↗ |
| 2023-02-09 | Herman Jenny | Officer | A-Award | A | Common Stock | 8,000 | 0.00 | — | 8,003 | — | ↗ |
| 2023-02-09 | Farid Ramy | Director / Officer | A-Award | A | Stock Option (right to buy) | 65,525 | 25.62 | 1.68M | 65,525 | — | ↗ |
| 2023-02-09 | Akinsanya Karen | Officer | A-Award | A | Stock Option (right to buy) | 63,270 | 23.29 | 1.47M | 63,270 | — | ↗ |
| 2023-02-09 | Abel Robert Lorne | Officer | A-Award | A | Common Stock | 10,545 | 0.00 | — | 10,545 | — | ↗ |
| 2023-02-02 | Tran Yvonne | Officer | S-Sale | D | Common Stock | 25,000 | 27.26 | 681.4K | 5,131 | — | ↗ |
| 2023-01-04 | Farid Ramy | Officer | M-Exempt | A | Common Stock | 66,886 | 1.20 | 80.3K | 251,318 | — | ↗ |
| 2022-08-18 | Porges Geoffrey Craig | Officer | A-Award | A | Stock Option (right to buy) | 180,000 | 0.00 | — | 180,000 | — | ↗ |
| 2022-08-11 | Thornberry Nancy | Director | M-Exempt | D | Stock Option (right to buy) | 4,950 | 11.52 | 57.0K | 41,870 | — | ↗ |
| 2022-06-15 | Thornberry Nancy | Director | A-Award | A | Stock Option (right to buy) | 14,907 | 0.00 | — | 14,907 | — | ↗ |
| 2022-06-15 | Sender Gary | Director | A-Award | A | Stock Option (right to buy) | 14,907 | 0.00 | — | 14,907 | — | ↗ |
| 2022-06-15 | Lynton Michael | Director | A-Award | A | Stock Option (right to buy) | 14,907 | 0.00 | — | 14,907 | — | ↗ |
| 2022-06-15 | Kapeller-Libermann Rosana | Director | A-Award | A | Stock Option (right to buy) | 14,907 | 24.51 | 365.4K | 14,907 | — | ↗ |
| 2022-06-15 | GINSBERG GARY L | Director | A-Award | A | Stock Option (right to buy) | 14,907 | 0.00 | — | 14,907 | — | ↗ |
| 2022-06-15 | Friesner Richard | Director | A-Award | A | Stock Option (right to buy) | 14,907 | 0.00 | — | 14,907 | — | ↗ |
| 2022-06-15 | Chodakewitz Jeffrey | Director | A-Award | A | Stock Option (right to buy) | 14,907 | 0.00 | — | 14,907 | — | ↗ |
| 2022-05-17 | OBEROI ARUN | Director | A-Award | A | Stock Option (right to buy) | 30,223 | 24.77 | 748.6K | 30,223 | — | ↗ |
| 2022-02-09 | Tran Yvonne | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 27.76 | 1.67M | 60,000 | — | ↗ |
| 2022-02-09 | Lorton Kenneth Patrick | Officer | A-Award | A | Stock Option (right to buy) | 70,000 | 27.76 | 1.94M | 70,000 | — | ↗ |
| 2022-02-09 | Herman Jenny | Officer | A-Award | A | Stock Option (right to buy) | 30,000 | 27.76 | 832.8K | 30,000 | — | ↗ |
| 2022-02-09 | Farid Ramy | Director / Officer | A-Award | A | Stock Option (right to buy) | 215,000 | 27.76 | 5.97M | 215,000 | — | ↗ |
| 2022-02-09 | Akinsanya Karen | Officer | A-Award | A | Stock Option (right to buy) | 80,000 | 27.76 | 2.22M | 80,000 | — | ↗ |
| 2022-02-09 | Abel Robert Lorne | Officer | A-Award | A | Stock Option (right to buy) | 70,000 | 27.76 | 1.94M | 70,000 | — | ↗ |
| 2021-12-13 | Abel Robert Lorne | Officer | M-Exempt | D | Stock Option (right to buy) | 15,601 | 17.00 | 265.2K | 94,756 | — | ↗ |
| 2021-10-15 | Akinsanya Karen | Officer | M-Exempt | A | Common Stock | 1,393 | 4.34 | 6.0K | 1,393 | — | ↗ |
| 2021-09-15 | Akinsanya Karen | Officer | M-Exempt | D | Stock Option (right to buy) | 1,394 | 4.34 | 6.0K | 44,591 | — | ↗ |
| 2021-09-13 | Abel Robert Lorne | Officer | M-Exempt | D | Stock Option (right to buy) | 15,602 | 17.00 | 265.2K | 110,357 | — | ↗ |
| 2021-09-02 | Lebowitz Joel | Officer | S-Sale | D | Common Stock | 3,874 | 64.62 | 250.4K | 0 | — | ↗ |
| 2021-09-01 | Lebowitz Joel | Officer | S-Sale | D | Common Stock | 1,700 | 64.53 | 109.7K | 0 | — | ↗ |
| 2021-08-16 | Akinsanya Karen | Officer | M-Exempt | A | Common Stock | 4,180 | 4.34 | 18.1K | 24,361 | — | ↗ |
| 2021-08-02 | Tran Yvonne | Officer | S-Sale | D | Common Stock | 3,950 | 67.39 | 266.2K | 13,181 | — | ↗ |
| 2021-07-19 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 11,986 | 69.19 | 829.3K | 6,103,042 | — | ↗ |
| 2021-07-16 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 3,177 | 66.08 | 209.9K | 6,191,926 | — | ↗ |
| 2021-07-15 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 9,280 | 65.79 | 610.5K | 6,245,181 | — | ↗ |
| 2021-07-14 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 13,950 | 68.43 | 954.6K | 6,257,391 | — | ↗ |
| 2021-07-14 | Lebowitz Joel | Officer | S-Sale | D | Common Stock | 305 | 69.45 | 21.2K | 0 | — | ↗ |
| 2021-07-13 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 18,220 | 69.67 | 1.27M | 6,321,505 | — | ↗ |
| 2021-07-12 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 1,483 | 75.18 | 111.5K | 6,340,625 | — | ↗ |
| 2021-07-09 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 5,345 | 75.90 | 405.7K | 6,360,655 | — | ↗ |
| 2021-07-08 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 5,673 | 73.75 | 418.4K | 6,400,395 | — | ↗ |
| 2021-07-07 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 12,109 | 72.49 | 877.8K | 6,438,319 | — | ↗ |
| 2021-07-06 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 1,011 | 76.23 | 77.1K | 6,450,428 | — | ↗ |
| 2021-07-02 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 9,177 | 75.27 | 690.8K | 6,485,094 | — | ↗ |
| 2021-07-01 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 14,816 | 75.83 | 1.12M | 6,521,030 | — | ↗ |
| 2021-06-30 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 30,021 | 76.06 | 2.28M | 6,542,434 | — | ↗ |
| 2021-06-29 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 16,724 | 77.75 | 1.30M | 6,584,439 | — | ↗ |
| 2021-06-28 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 33,323 | 79.08 | 2.64M | 6,601,476 | — | ↗ |
| 2021-06-25 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 3,400 | 76.77 | 261.0K | 6,874,191 | — | ↗ |
| 2021-06-24 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 41,319 | 78.48 | 3.24M | 6,877,591 | — | ↗ |
| 2021-06-23 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 32,536 | 76.77 | 2.50M | 6,977,634 | — | ↗ |
| 2021-06-22 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 5,311 | 74.60 | 396.2K | 7,133,861 | — | ↗ |
| 2021-06-21 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 36,190 | 75.22 | 2.72M | 7,140,258 | — | ↗ |
| 2021-06-21 | Abel Robert Lorne | Officer | M-Exempt | D | Stock Option (right to buy) | 2,214 | 2.92 | 6.5K | 0 | — | ↗ |
| 2021-06-18 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 26,870 | 73.86 | 1.98M | 7,225,535 | — | ↗ |
| 2021-06-17 | Thornberry Nancy | Director | A-Award | A | Stock Option (right to buy) | 8,736 | 76.08 | 664.6K | 8,736 | — | ↗ |
| 2021-06-17 | Sender Gary | Director | A-Award | A | Stock Option (right to buy) | 8,736 | 76.08 | 664.6K | 8,736 | — | ↗ |
| 2021-06-17 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 33,219 | 76.09 | 2.53M | 7,261,960 | — | ↗ |
| 2021-06-17 | Lynton Michael | Director | A-Award | A | Stock Option (right to buy) | 8,736 | 76.08 | 664.6K | 8,736 | — | ↗ |
| 2021-06-17 | Kapeller-Libermann Rosana | Director | A-Award | A | Stock Option (right to buy) | 8,736 | 76.08 | 664.6K | 8,736 | — | ↗ |
| 2021-06-17 | GINSBERG GARY L | Director | A-Award | A | Stock Option (right to buy) | 8,736 | 76.08 | 664.6K | 8,736 | — | ↗ |
| 2021-06-17 | Friesner Richard | Director | A-Award | A | Stock Option (right to buy) | 8,736 | 76.08 | 664.6K | 8,736 | — | ↗ |
| 2021-06-17 | Chodakewitz Jeffrey | Director | A-Award | A | Stock Option (right to buy) | 8,736 | 76.08 | 664.6K | 8,736 | — | ↗ |
| 2021-06-16 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 19,107 | 74.40 | 1.42M | 7,314,209 | — | ↗ |
| 2021-06-15 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 8,723 | 73.38 | 640.1K | 7,393,236 | — | ↗ |
| 2021-06-14 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 3,040 | 78.34 | 238.2K | 7,401,959 | — | ↗ |
| 2021-06-14 | Lebowitz Joel | Officer | S-Sale | D | Common Stock | 200 | 78.60 | 15.7K | 0 | — | ↗ |
| 2021-06-08 | Akinsanya Karen | Officer | M-Exempt | A | Common Stock | 10,242 | 4.34 | 44.5K | 10,242 | — | ↗ |
| 2021-06-07 | Kapeller-Libermann Rosana | Director | S-Sale | D | Common Stock | 1,000 | 75.00 | 75.0K | 0 | — | ↗ |
| 2021-06-07 | Akinsanya Karen | Officer | S-Sale | D | Common Stock | 6,479 | 75.10 | 486.6K | 0 | — | ↗ |
| 2021-05-26 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 300 | 69.48 | 20.8K | 7,445,422 | — | ↗ |
| 2021-05-25 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 2,780 | 67.07 | 186.4K | 7,489,104 | — | ↗ |
| 2021-05-24 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 23,067 | 65.47 | 1.51M | 7,495,296 | — | ↗ |
| 2021-05-20 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 16,154 | 64.10 | 1.04M | 7,526,444 | — | ↗ |
| 2021-05-19 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 2,394 | 61.96 | 148.3K | 7,567,084 | — | ↗ |
| 2021-05-18 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 8,739 | 64.86 | 566.8K | 7,569,478 | — | ↗ |
| 2021-05-18 | Lebowitz Joel | Officer | S-Sale | D | Common Stock | 5,574 | 64.45 | 359.2K | 0 | — | ↗ |
| 2021-05-14 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 2,800 | 58.34 | 163.4K | 7,620,080 | — | ↗ |
| 2021-05-13 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 5,774 | 58.10 | 335.5K | 7,642,106 | — | ↗ |
| 2021-05-12 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 300 | 62.33 | 18.7K | 7,647,880 | — | ↗ |
| 2021-05-07 | Lorton Kenneth Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 1,442 | 17.00 | 24.5K | 87,199 | — | ↗ |
| 2021-05-06 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 3,630 | 67.66 | 245.6K | 7,674,870 | — | ↗ |
| 2021-05-05 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 11,641 | 68.74 | 800.2K | 7,721,239 | — | ↗ |
| 2021-05-05 | Abel Robert Lorne | Officer | M-Exempt | D | Stock Option (right to buy) | 2,496 | 1.57 | 3.9K | 0 | — | ↗ |
| 2021-05-04 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 17,865 | 69.88 | 1.25M | 7,737,195 | — | ↗ |
| 2021-04-29 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 4,747 | 74.09 | 351.7K | 7,788,533 | — | ↗ |
| 2021-04-28 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 26,754 | 76.58 | 2.05M | 7,797,845 | — | ↗ |
| 2021-04-27 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 730 | 78.62 | 57.4K | 7,828,280 | — | ↗ |
| 2021-04-21 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 13,292 | 72.41 | 962.4K | 7,864,405 | — | ↗ |
| 2021-04-20 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 5,420 | 70.70 | 383.2K | 7,902,019 | — | ↗ |
| 2021-04-19 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 3,210 | 76.83 | 246.6K | 7,924,405 | — | ↗ |
| 2021-04-15 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 25,881 | 78.52 | 2.03M | 7,954,405 | — | ↗ |
| 2021-04-14 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 16,831 | 78.63 | 1.32M | 8,003,697 | — | ↗ |
| 2021-04-14 | Lebowitz Joel | Officer | M-Exempt | D | Stock Option (right to buy) | 5,574 | 4.34 | 24.2K | 105,904 | — | ↗ |
| 2021-04-13 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 11,786 | 73.89 | 870.9K | 8,063,019 | — | ↗ |
| 2021-04-09 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 18,473 | 74.18 | 1.37M | 8,077,385 | — | ↗ |
| 2021-04-08 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 23,495 | 76.32 | 1.79M | 8,122,914 | — | ↗ |
| 2021-04-07 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 9,543 | 75.94 | 724.6K | 8,157,446 | — | ↗ |
| 2021-04-01 | Weiser Jorg | Director / Officer | M-Exempt | A | Common Stock | 418 | 4.34 | 1.8K | 117,470 | — | ↗ |
| 2021-04-01 | Tran Yvonne | Officer | S-Sale | D | Common Stock | 400 | 81.39 | 32.6K | 17,131 | — | ↗ |
| 2021-04-01 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 5,849 | 80.59 | 471.4K | 8,182,235 | — | ↗ |
| 2021-04-01 | Daniel Jennifer | Officer | S-Sale | D | Common Stock | 418 | 78.34 | 32.7K | 6,688 | — | ↗ |
| 2021-03-31 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 13,256 | 75.20 | 996.9K | 8,311,806 | — | ↗ |
| 2021-03-30 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 14,728 | 71.81 | 1.06M | 8,326,052 | — | ↗ |
| 2021-03-24 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 5,439 | 70.29 | 382.3K | 8,368,906 | — | ↗ |
| 2021-03-23 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 100 | 77.52 | 7.8K | 8,416,152 | — | ↗ |
| 2021-03-23 | D'Cruz Cony | Officer | S-Sale | D | Common Stock | 2,800 | 79.00 | 221.2K | 0 | — | ↗ |
| 2021-03-22 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 19,361 | 81.86 | 1.58M | 8,473,736 | — | ↗ |
| 2021-03-18 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 100 | 79.86 | 8.0K | 8,516,052 | — | ↗ |
| 2021-03-17 | Weiser Jorg | Director / Officer | S-Sale | D | Common Stock | 904 | 80.85 | 73.1K | 117,352 | — | ↗ |
| 2021-03-17 | SHAW DAVID E | 10% Owner | S-Sale | D | Common Stock, par value $0.01 per share | 895 | 81.80 | 73.2K | 8,546,052 | — | ↗ |
| 2021-03-16 | Weiser Jorg | Director / Officer | S-Sale | D | Common Stock | 37,060 | 82.00 | 3.04M | 126,356 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-120.8K
Shares Outstanding
74.72M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Ramy Farid President and Chief Executive Officer | 730.0K | — | 796.5K | 1.97M | 570.9K | 14.8K | 4.08M | 67.75% | ↗ |
| 2 | 2025 | Karen Akinsanya President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | 600.0K | — | 331.9K | 834.8K | 331.2K | 13.0K | 2.11M | 55.27% | ↗ |
| 3 | 2025 | Geoffrey Porges Chief Financial Officer | 317.7K | — | 265.5K | 667.9K | — | 770.8K | 2.02M | 46.16% | ↗ |
| 4 | 2025 | Mannix Aklian Chief Commercial Officer, Global Head of Software Sales & Marketing | 286.7K | 75.0K | 301.5K | 1.15M | 180.0K | 14.5K | 2.01M | 72.35% | ↗ |
| 5 | 2025 | Yvonne Tran Chief Legal Officer and Chief People Officer | 584.0K | — | 265.5K | 667.9K | 268.6K | 14.8K | 1.80M | 51.83% | ↗ |
| 6 | 2025 | Richie Jain Chief Financial Officer | 503.7K | — | 588.5K | 459.5K | 231.9K | 12.3K | 1.80M | 58.35% | ↗ |
| 7 | 2024 | Ramy Farid President and Chief Executive Officer | 704.1K | — | — | 3.16M | 526.3K | 14.6K | 4.41M | 71.75% | ↗ |
| 8 | 2024 | Karen Akinsanya President of RD, Therapeutics | 562.6K | — | — | 1.81M | 355.9K | 12.9K | 2.74M | 65.97% | ↗ |
| 9 | 2024 | Karen Akinsanya President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | 562.6K | — | — | 1.81M | 355.9K | 12.9K | 2.74M | 65.97% | ↗ |
| 10 | 2024 | Geoffrey Porges Chief Financial Officer | 627.1K | — | — | 1.35M | 396.7K | 14.6K | 2.39M | 56.60% | ↗ |
| 11 | 2024 | Robert Abel Chief Scientific Officer, Platform | 460.0K | — | — | 1.40M | 264.5K | 12.3K | 2.13M | 65.44% | ↗ |
| 12 | 2024 | Patrick Lorton Chief Operating Officer, Software and Chief Technology Officer | 460.0K | — | — | 1.40M | 264.5K | 12.3K | 2.13M | 65.44% | ↗ |
| 13 | 2023 | Margaret Dugan Chief Medical Officer | 218.6K | 100.0K | 598.4K | 2.15M | 78.5K | 4.2K | 3.15M | 87.26% | ↗ |
| 14 | 2023 | Ramy Farid President and Chief Executive Officer | 677.0K | — | — | 2.07M | 365.6K | 13.8K | 3.12M | 66.19% | ↗ |
| 15 | 2023 | Robert Abel Chief Scientific Officer, Platform | 410.0K | — | 245.6K | 882.7K | 147.6K | 11.8K | 1.70M | 66.46% | ↗ |
| 16 | 2023 | Karen Akinsanya President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | 541.0K | — | — | 882.7K | 243.5K | 13.3K | 1.68M | 52.53% | ↗ |
| 17 | 2023 | Karen Akinsanya President of RD, Therapeutics | 541.0K | — | — | 882.7K | 243.5K | 13.3K | 1.68M | 52.53% | ↗ |
| 18 | 2023 | Geoffrey Porges Chief Financial Officer | 603.0K | — | — | 763.6K | 271.4K | 13.8K | 1.65M | 46.23% | ↗ |
| 19 | 2022 | Ramy Farid President and Chief Executive Officer | 651.0K | — | — | 2.88M | 375.0K | 12.7K | 3.92M | 73.48% | ↗ |
| 20 | 2022 | Geoffrey Porges Chief Financial Officer | 213.5K | 230.0K | — | 2.70M | 103.0K | 8.6K | 3.25M | 82.94% | ↗ |
| 21 | 2022 | Karen Akinsanya President, RD Therapeutics | 515.4K | — | — | 1.07M | 249.6K | 12.7K | 1.85M | 57.93% | ↗ |
| 22 | 2022 | Yvonne Tran Chief Legal Officer | 475.0K | — | — | 803.0K | 182.4K | 12.7K | 1.47M | 54.51% | ↗ |
| 23 | 2022 | Robert Abel Chief Computational Scientist and Head of Modeling RD | 374.0K | — | — | 936.8K | 143.6K | 10.8K | 1.47M | 63.94% | ↗ |
| 24 | 2022 | Jenny Herman Senior Vice President, Finance and Corporate Controller | 384.2K | — | — | 401.5K | 126.7K | 10.8K | 923.1K | 43.49% | ↗ |
| 25 | 2022 | Joel Lebowitz Former Chief Financial Officer | 71.7K | — | — | — | — | 374.9K | 446.5K | 0.00% | ↗ |
| 26 | 2021 | Ramy Farid President and Chief Executive Officer | 620.0K | — | — | 7.47M | 390.6K | 12.1K | 8.49M | 87.96% | ↗ |
| 27 | 2021 | Karen Akinsanya President, RD Therapeutics | 460.0K | — | — | 3.98M | 193.2K | 12.1K | 4.65M | 85.69% | ↗ |
| 28 | 2021 | Robert Abel Chief Computational Scientist and Head of Modeling RD | 356.0K | — | — | 3.98M | 149.5K | 10.3K | 4.50M | 88.54% | ↗ |
| 29 | 2021 | Patrick Lorton Chief Operating Officer, Software and Chief Technology Officer | 352.0K | — | — | 3.98M | 147.8K | 10.3K | 4.49M | 88.65% | ↗ |
| 30 | 2021 | Joel Lebowitz Former Chief Financial Officer | 410.0K | — | — | 1.99M | 172.2K | 12.1K | 2.59M | 77.02% | ↗ |
| 31 | 2020 | Ramy Farid President and Chief Executive Officer | 525.8K | — | — | 7.50M | 473.2K | 11.9K | 8.51M | 88.12% | ↗ |
| 32 | 2020 | Yvonne Tran Executive Vice President and Chief Legal Officer | 428.0K | — | — | 1.68M | 256.8K | 11.9K | 2.38M | 70.67% | ↗ |
| 33 | 2020 | Karen Akinsanya Executive Vice President, Chief Biomedical Scientist, Head of Discovery RD | 400.0K | — | — | 1.68M | 240.0K | 11.9K | 2.33M | 72.03% | ↗ |
| 34 | 2020 | Karen Akinsanya President, RD Therapeutics | 400.0K | — | — | 1.68M | 240.0K | 11.9K | 2.33M | 72.03% | ↗ |
| 35 | 2019 | Ramy Farid President and Chief Executive Officer | 478.0K | — | — | — | 143.4K | 11.7K | 633.1K | 0.00% | ↗ |
| 36 | 2019 | Yvonne Tran Executive Vice President and Chief Legal Officer | 415.0K | — | — | — | 124.5K | 10.0K | 549.5K | 0.00% | ↗ |
| 37 | 2019 | Karen Akinsanya Executive Vice President, Chief Biomedical Scientist, Head of Discovery RD | 330.0K | — | — | — | 99.0K | 11.7K | 440.7K | 0.00% | ↗ |
| 38 | 2019 | Karen Akinsanya President, RD Therapeutics | 330.0K | — | — | — | 99.0K | 11.7K | 440.7K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ramy Farid | Chief Executive Officer, President & Director | 1M | — |
| Karen Akinsanya | President, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships | 944.2K | — |
| Yvonne Tran | Corporate Secretary, Chief Legal & People Officer | 867.4K | female |
| Richie Jain | Executive Vice President, Chief Financial Officer & Treasurer | 748.0K | male |
| Robert Lorne Abel | Executive Vice President, Chief Scientific Officer of Platform and Head of Modeling R&D | 736.8K | — |
| Kenneth Patrick Lorton | Executive Vice President, Chief Technology Officer & Chief Operating Officer of Software | 736.8K | male |
| Mannix Aklian | Executive VP, Chief Commercial Officer and Global Head of Software Sales & Marketing | 556.2K | male |
| Jenny Herman | Chief Accounting Officer | 521.6K | female |
| Richard A. Friesner | Co-Founder, Scientific Advisory Chairman and Director | 486.8K | — |
| Jaren Irene Madden | Chief Corporate Affairs Officer & Head of Investor Relations | — | female |
| Shane Brauner | Executive Vice President & Chief Information Officer | — | male |
| Therese Abrams | Principal Accounting Officer | — | female |
ESG Rating
ESG Score History MEDICAL - HEALTHCARE INFORMATION SERVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SDGR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
